Ann-Lii Cheng
research.mc.ntu.edu.tw
0000-0002-9152-6512
National Taiwan University
7 papers found
Refreshing results…
Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women
IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia
Overall Survival and Objective Response in Advanced Unresectable Hepatocellular Carcinoma: A Subanalysis of the REFLECT Study
Missing publications? Search for publications with a matching author name.